Levels of circulating CD45dimCD34+VEGFR2+ progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors

CD133+ circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients

(2009) L Vroling et al.   BRITISH JOURNAL OF CANCER

High Levels of Circulating VEGFR2+ Bone Marrow-Derived Progenitor Cells Correlate with Metastatic Disease in Patients with Pediatric Solid Malignancies

(2009) M. Taylor et al.   CLINICAL CANCER RESEARCH

Endothelial progenitor cell: ongoing controversy for defining these cells and their role in neoangiogenesis in the murine system

(2009) Mervin C Yoder et al.   CURRENT OPINION IN HEMATOLOGY

Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial

(2009) Bernard Escudier et al.   JOURNAL OF CLINICAL ONCOLOGY

Circulating endothelial cells in oncology: pitfalls and promises

(2008) M H Strijbos et al.   BRITISH JOURNAL OF CANCER

Quantification of circulating mature endothelial cells using a whole blood four-color flow cytometric assay

(2008) Nathalie Jacques et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth

(2008) S. Purhonen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Endothelial Progenitor Cells Control the Angiogenic Switch in Mouse Lung Metastasis

(2008) D. Gao et al.   SCIENCE